SAREPTA THERAP (AB3A BE) stock market data APIs
€15.2566
0(0%)
as of September 17, 2025
Try our APIs with
free plan!
SAREPTA THERAP Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for AB3A.BE.
Prev. Close
15.2566
Open
15.2566
High
15.2566
Low
15.2566
52 wk Range
9.55-130.25
Market Cap
6 592 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get SAREPTA THERAP data using free add-ons & libraries
Get SAREPTA THERAP Fundamental Data
SAREPTA THERAP Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SAREPTA THERAP News
New
MLAB Biosciences Appoints Dr. Edward M. Kaye as Chair of Scientific Advisory Board
NEEDHAM, Mass., Sept. 15, 2025 /PRNewswire/ -- MLAB Biosciences, a biotechnology company pioneering novel therapies for neuromuscular disease, today announced the appointment of Edward M. Kaye, M.D., ...
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2025-2026 Academic Year
– Recipients include 20 individuals living with Duchenne and five siblings of individuals living with the condition – Now in its 8th year, program has awarded more than 150 scholarships CAMBRIDG...
Sarepta Therapeutics (SRPT) Fell Despite Reporting Good Results
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Mid-c...
Why Elanco (ELAN) Stock Is Trading Up Today
What Happened? Shares of animal health company Elanco (NYSE:ELAN) jumped 4.4% in the morning session after the company announced it will be joining the S&P MidCap 400 index. The animal health compan...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
